Drug-resistant malaria—changing patterns mean difficult decisions
- 1 January 1985
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 79 (6) , 748-758
- https://doi.org/10.1016/0035-9203(85)90108-7
Abstract
The question is approached through three examples. Ross's model, although very simple and formulated a priori, yielded important epidemiplogical insights: the existence of a threshold contact rate (vectorial capacity); the decreasing sensitivity of the endemic level to changes in the contact rate, as the latter gets larger; the return to the same equilibrium endemic level, as long as the contact rate remains the same; the progressively decreasing impact of a given reduction in the contact rate until a new equilibrium is reached. The second example is Macdonald's model, in particular his sensitivity analysis; two constraints are pointed out: the weakest point, on which to concentrate control efforts, cannot be identified automatically by the sensitivity analysis; the calculation of the expected impact of an intervention commonly assumes too much uniformity (e.g. of human of vector behaviour) and this commonly leads to exaggerated expectations. The third example is the Garki model, briefly considered in terms of its assumptions, of its behaviour, of its actual utilization (only for teaching, so far), and of the cost of its development. Looking forward, three uses of models are discussed. It is suggested that, critically used, they have a place in training, in planning control and in research. With respect to their application to planning, it is argued that the need for new data is not necessarily great, also that some rather difficult direct measurements might be substituted by indirect measurements, a point illustrated by the expected relationships, following the Garki model, between different dimensions of “intensity” of malaria. With respect to research, it is suggested that simulations may assist in clarifying discussions around the expected impact of malaria vaccines, hence guide their field testing.Keywords
This publication has 37 references indexed in Scilit:
- MALOPRIM AND AGRANULOCYTOSISThe Lancet, 1983
- Evaluation of Amodiaquine Treatment of Chloroquine-Resistant Plasmodium Falciparum Malaria on Zanzibar, 1982The American Journal of Tropical Medicine and Hygiene, 1983
- MEFLOQUINE RESISTANCE OF FALCIPARUM MALARIA FROM TANZANIA ENHANCED BY TREATMENTThe Lancet, 1983
- Multiple drug resistance in falciparum malaria from BrazilTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- TYPE II MEFLOQUINE RESISTANCE IN THAILANDThe Lancet, 1982
- Failure of Chloroquine prophylaxis in Plasmodium falciparum from East AfricaJAMA, 1981
- Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution techniqueAntimicrobial Agents and Chemotherapy, 1979
- Amodiaquine Resistant Falciparum Malaria in Thailand *The American Journal of Tropical Medicine and Hygiene, 1975
- Mass treatment with pyrimethamine A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952 — September 1953Transactions of the Royal Society of Tropical Medicine and Hygiene, 1958
- Experiments with antimalarial drugs in manTransactions of the Royal Society of Tropical Medicine and Hygiene, 1957